Log In
BCIQ
Print this Print this
 

SKL-G

  Manage Alerts
Collapse Summary General Information
Company SK Biopharmaceuticals Co. Ltd.
DescriptionNot disclosed
Molecular Target
Mechanism of ActionUndisclosed
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma
Regulatory Designation
PartnerAriBio

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/15/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today